247 related articles for article (PubMed ID: 35022084)
21. The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.
Zhang J; Vlasevska S; Wells VA; Nataraj S; Holmes AB; Duval R; Meyer SN; Mo T; Basso K; Brindle PK; Hussein S; Dalla-Favera R; Pasqualucci L
Cancer Discov; 2017 Mar; 7(3):322-337. PubMed ID: 28069569
[TBL] [Abstract][Full Text] [Related]
22. Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
Küppers R; Sousa AB; Baur AS; Strickler JG; Rajewsky K; Hansmann ML
Mol Med; 2001 May; 7(5):285-92. PubMed ID: 11474574
[TBL] [Abstract][Full Text] [Related]
23. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
Kumar E; Pickard L; Okosun J
Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
[TBL] [Abstract][Full Text] [Related]
24. The follicular lymphoma tumor microenvironment at single-cell and spatial resolution.
Radtke AJ; Roschewski M
Blood; 2024 Mar; 143(12):1069-1079. PubMed ID: 38194685
[TBL] [Abstract][Full Text] [Related]
25. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from the microscope.
Harris NL
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):158-62. PubMed ID: 25696849
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies.
Serganova I; Chakraborty S; Yamshon S; Isshiki Y; Bucktrout R; Melnick A; Béguelin W; Zappasodi R
Front Cell Dev Biol; 2021; 9():805195. PubMed ID: 35071240
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathogenesis of follicular lymphoma.
Kishimoto W; Nishikori M
J Clin Exp Hematop; 2014; 54(1):23-30. PubMed ID: 24942943
[TBL] [Abstract][Full Text] [Related]
28. EZH2 mutations are frequent and represent an early event in follicular lymphoma.
Bödör C; Grossmann V; Popov N; Okosun J; O'Riain C; Tan K; Marzec J; Araf S; Wang J; Lee AM; Clear A; Montoto S; Matthews J; Iqbal S; Rajnai H; Rosenwald A; Ott G; Campo E; Rimsza LM; Smeland EB; Chan WC; Braziel RM; Staudt LM; Wright G; Lister TA; Elemento O; Hills R; Gribben JG; Chelala C; Matolcsy A; Kohlmann A; Haferlach T; Gascoyne RD; Fitzgibbon J
Blood; 2013 Oct; 122(18):3165-8. PubMed ID: 24052547
[TBL] [Abstract][Full Text] [Related]
29. Biological and clinical significance of epigenetic alterations in B-cell lymphomas.
Ennishi D
Int J Hematol; 2022 Dec; 116(6):821-827. PubMed ID: 36208393
[TBL] [Abstract][Full Text] [Related]
30. Vulnerabilities in the tumor and microenvironment in follicular lymphoma.
Araujo-Ayala F; Pérez-Galán P; Campo E
Hematol Oncol; 2021 Jun; 39 Suppl 1():83-87. PubMed ID: 34105816
[TBL] [Abstract][Full Text] [Related]
31. Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse.
Pangault C; Amé-Thomas P; Rossille D; Dulong J; Caron G; Nonn C; Chatonnet F; Desmots F; Launay V; Lamy T; Fest T; Tarte K
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33028033
[TBL] [Abstract][Full Text] [Related]
32. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
Rimsza LM; Jaramillo MC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
[TBL] [Abstract][Full Text] [Related]
33. Transformed follicular lymphoma.
Fischer T; Zing NPC; Chiattone CS; Federico M; Luminari S
Ann Hematol; 2018 Jan; 97(1):17-29. PubMed ID: 29043381
[TBL] [Abstract][Full Text] [Related]
34. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
[TBL] [Abstract][Full Text] [Related]
35. The t(14;18) translocation is absent from endothelial and follicular dendritic cells of follicular lymphoma (FL) and shows heterogeneous presence in preserved FL mantle zones.
Kosmidis P; Mankel B; Fend F; Adam P
Diagn Pathol; 2018 May; 13(1):25. PubMed ID: 29720207
[TBL] [Abstract][Full Text] [Related]
36. Grade I, II and III Follicular Lymphomas Express Ig V
Csernus B; Timár B; Fülöp Z; Matolcsy A
Pathol Oncol Res; 2020 Oct; 26(4):2765-2772. PubMed ID: 32705429
[TBL] [Abstract][Full Text] [Related]
37. DC-SIGN-expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma.
Amin R; Mourcin F; Uhel F; Pangault C; Ruminy P; Dupré L; Guirriec M; Marchand T; Fest T; Lamy T; Tarte K
Blood; 2015 Oct; 126(16):1911-20. PubMed ID: 26272216
[TBL] [Abstract][Full Text] [Related]
38. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
[TBL] [Abstract][Full Text] [Related]
39. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
40. Treating lymphoma is now a bit EZ-er.
Morin RD; Arthur SE; Assouline S
Blood Adv; 2021 Apr; 5(8):2256-2263. PubMed ID: 33904892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
